open access

Vol 45, Supp. I (2007)
ORIGINAL PAPERS
Published online: 2008-04-15
Submitted: 2011-12-19
Get Citation

Clomiphene citrate challenge test and serum anti-MĂźllerian hormone levels in women with menstrual irregularities and/or infertility.

Tomasz Milewicz, Józef Krzysiek, Barbara Blakała, Magdalena Krzyczkowska-Sendrakowska, Stanisław Radowicki, Olga Kacalska, Marta Zabińska

open access

Vol 45, Supp. I (2007)
ORIGINAL PAPERS
Published online: 2008-04-15
Submitted: 2011-12-19

Abstract

AIM
Evaluation of CCCT results and anti-MĂźllerian hormone (AMH) plasma levels in women with menstrual cycle irregularities and/or infertility.

PATIENTS AND METHODS
70 patients with menstrual cycle disturbances were recruited to the study. Clomiphene citrate challenge test (CCCT) was carried out in each patient enrolled. At day 3 of the cycle plasma basic levels of FSH, estradiol, progesterone, IGFBP-1, TSH, prolactin, DHEAS and anti-MĂźllerian hormone were measured. At day 10 of the cycle plasma levels of FSH and estradiol were evaluated. Plasma levels of hormones were measured by commercially available ELISA kits.

RESULTS
50 women with normal result of CCCT (group A) had higher mean plasma level of AMH compared to 20 women with abnormal result of CCCT (group B). Mean plasma FSH level at day 3 of the cycle was lower in group A compared to group B. There were no other statistically significant differences in mean values of assessed parameters between groups A and B. Taking into account all patients enrolled to the study AMH correlated significantly with patients' age and plasma levels of FSH at day 3 and day 10 of the cycle). Basic AMH plasma levels in group A correlated negatively with plasma levels of FSH at day 3 and day 10. In group B plasma levels of FSH at day 10 of the cycle also correlated with basic AMH plasma levels. Plasma levels of estradiol at day 10 of the cycle were related inversely with basic AMH plasma levels in group A, but directly in group B.

CONCLUSION
It should be recommended to perform the CCCT before infertility treatment. Evaluation of the anti-MĂźllerian hormone plasma level reflects the results of the CCCT.

Abstract

AIM
Evaluation of CCCT results and anti-MĂźllerian hormone (AMH) plasma levels in women with menstrual cycle irregularities and/or infertility.

PATIENTS AND METHODS
70 patients with menstrual cycle disturbances were recruited to the study. Clomiphene citrate challenge test (CCCT) was carried out in each patient enrolled. At day 3 of the cycle plasma basic levels of FSH, estradiol, progesterone, IGFBP-1, TSH, prolactin, DHEAS and anti-MĂźllerian hormone were measured. At day 10 of the cycle plasma levels of FSH and estradiol were evaluated. Plasma levels of hormones were measured by commercially available ELISA kits.

RESULTS
50 women with normal result of CCCT (group A) had higher mean plasma level of AMH compared to 20 women with abnormal result of CCCT (group B). Mean plasma FSH level at day 3 of the cycle was lower in group A compared to group B. There were no other statistically significant differences in mean values of assessed parameters between groups A and B. Taking into account all patients enrolled to the study AMH correlated significantly with patients' age and plasma levels of FSH at day 3 and day 10 of the cycle). Basic AMH plasma levels in group A correlated negatively with plasma levels of FSH at day 3 and day 10. In group B plasma levels of FSH at day 10 of the cycle also correlated with basic AMH plasma levels. Plasma levels of estradiol at day 10 of the cycle were related inversely with basic AMH plasma levels in group A, but directly in group B.

CONCLUSION
It should be recommended to perform the CCCT before infertility treatment. Evaluation of the anti-MĂźllerian hormone plasma level reflects the results of the CCCT.

Get Citation
About this article
Title

Clomiphene citrate challenge test and serum anti-MĂźllerian hormone levels in women with menstrual irregularities and/or infertility.

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 45, Supp. I (2007)

Pages

119-121

Published online

2008-04-15

Authors

Tomasz Milewicz
Józef Krzysiek
Barbara Blakała
Magdalena Krzyczkowska-Sendrakowska
Stanisław Radowicki
Olga Kacalska
Marta Zabińska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl